Turnstone Biologics Statistics

Total Valuation

TSBX has a market cap or net worth of $10.87 million. The enterprise value is -$32.95 million.

Market Cap	10.87M
Enterprise Value	-32.95M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

TSBX has 23.13 million shares outstanding. The number of shares has increased by 259.20% in one year.

Current Share Class	23.13M
Shares Outstanding	23.13M
Shares Change (YoY)	+259.20%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	30.31%
Float	14.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.24
P/TBV Ratio	0.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.04.

Current Ratio	3.75
Quick Ratio	3.32
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -94.47% and return on invested capital (ROIC) is -60.51%.

Return on Equity (ROE)	-94.47%
Return on Assets (ROA)	-51.94%
Return on Capital (ROIC)	-60.51%
Revenue Per Employee	n/a
Profits Per Employee	-$930,188
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-963,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-84.04%
50-Day Moving Average	0.52
200-Day Moving Average	2.04
Relative Strength Index (RSI)	44.31
Average Volume (20 Days)	599,512

Short Selling Information

The latest short interest is 367,208, so 1.59% of the outstanding shares have been sold short.

Short Interest	367,208
Short Previous Month	387,819
Short % of Shares Out	1.59%
Short % of Float	2.57%
Short Ratio (days to cover)	2.36

Income Statement

Revenue	n/a
Gross Profit	-60.38M
Operating Income	-78.86M
Pretax Income	-75.09M
Net Income	-74.42M
EBITDA	-76.71M
EBIT	-78.86M
Earnings Per Share (EPS)	-$3.23

Full Income Statement

Balance Sheet

The company has $45.28 million in cash and $1.70 million in debt, giving a net cash position of $43.59 million or $1.88 per share.

Cash & Cash Equivalents	45.28M
Total Debt	1.70M
Net Cash	43.59M
Net Cash Per Share	$1.88
Equity (Book Value)	43.64M
Book Value Per Share	1.89
Working Capital	37.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$66.47 million and capital expenditures -$248,000, giving a free cash flow of -$66.71 million.

Operating Cash Flow	-66.47M
Capital Expenditures	-248,000
Free Cash Flow	-66.71M
FCF Per Share	-$2.88

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-259.20%
Shareholder Yield	-259.20%
Earnings Yield	-667.52%
FCF Yield	-598.44%

Analyst Forecast

The average price target for TSBX is $4.75, which is 910.64% higher than the current price. The consensus rating is "Buy".

Price Target	$4.75
Price Target Difference	910.64%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSBX has an Altman Z-Score of -7.01 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.01
Piotroski F-Score	1